ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: type 1 diabetes

Is B a Key to Autoimmune Therapy?: B Cell-Targeted Therapies in Autoimmune Disease

Jennifer Anolik, MD, PhD  |  January 1, 2010

A perspective on B cell–targeted therapies in autoimmune disease

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Autoimmuneautoimmune inflammatory diseasesB cellsinflammationRheumatoid arthritisSLESystemic lupus erythematosus

Cellular Therapy of Autoimmune Disease

Alan Tyndall, MD  |  November 1, 2008

Is a novel treatment breakthrough on the horizon?

Filed under:Clinical Criteria/GuidelinesConditionsResearch Rheum Tagged with:Autoimmune diseaseResearchTreatment

REF Reaches for a Cure

David Holzman  |  September 1, 2007

ACR Research and Education Foundation launches campaign to find RA cure

Filed under:ConditionsFrom the CollegeResearch RheumRheumatoid Arthritis Tagged with:ACR Research and Education Foundation (REF)Basic researchClinical researchGrantsREFResearchRheumatoid arthritisRheumatoid Arthritis (RA)translational researchWithin Our Reach

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD  |  November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

Filed under:ACR ConvergenceMeeting ReportsMyositisOther Rheumatic ConditionsSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNconnective tissue diseaseLupusLupus nephritismyositisRaynaud’s phenomenonRheumatic DiseaseSjögren's Diseasesystemic lupus erythematosus (SLE)

Lupus Nephritis: A Serious Manifestation of Systemic Lupus Erythematosus

Graciela S. Alarcón, MD, MPH, MACR  |  November 5, 2025

In this review, some of the many abstracts on research into lupus nephritis presented at ACR Convergence 2025 are highlighted. The abstracts selected demonstrate the advances made on the early recognition of the condition, as well as offering some hope in terms of achieving better outcomes.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNLupus nephritisresearch reviews

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 28, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on cutaneous manifestations of rheumatic diseases, gout, macrophage activation syndrome and vasculitis.

Filed under:ACR ConvergenceAmerican College of RheumatologyGout and Crystalline ArthritisMeeting ReportsOther Rheumatic ConditionsSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025GoutLupusmacrophage activation syndromeMethotrexatesystemic lupus erythematosus (SLE)Vasculitis

Gout & Cardiometabolic Co-Morbidities

Jason Liebowitz, MD, FACR  |  October 28, 2025

ACR Convergence 2025 experts explore gout’s deep ties to MetS, insulin resistance and cardiovascular mortality, weighing new data on colchicine, febuxostat and SGLT2 inhibitors.

Filed under:ACR ConvergenceConditionsGout and Crystalline Arthritis Tagged with:ACR Convergence 2025AllopurinolCardiovascular diseasecardiovascular riskColchicinecomorbiditiesFebuxostatGout Resource Centerhyperuricemiametabolic syndromeSGLT2 inhibitors

Let’s Discuss: Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 27, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on SLE and lupus nephritis, inflammatory brain diseases, drug management of rheumatic diseases and mimics of inflammatory myopathies.

Filed under:ACR ConvergenceMeeting ReportsOther Rheumatic ConditionsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNdrugInflammatory Brain DiseasesInflammatory MyopathiesLupusLupus nephritisRheumatic Diseasesystemic lupus erythematosus (SLE)

What Clinicians Should Know About Midfoot Osteoarthritis

Yvonne M. Golightly, PT, MS, PhD, Jill Halstead, BSc, MSc, PhD, MRCPod, John B. Arnold, PhD, Lara S. Chapman, MSc, BPod, Catherine J. Bowen, PhD, BPod, Marian T. Hannan, DSc, MPH, Hylton B. Menz, PhD, BPod, Kade L. Paterson, PhD, BPod, BAppSci(Hons) & Martin J. Thomas, PhD, MCSP  |  October 8, 2025

Midfoot OA experts offer an overview of a common, but under-recognized, form of OA, & discuss quality of life impacts, treatments, clinical evaluation procedures & the critical need for further research.

Filed under:ConditionsGuidanceInterprofessional PerspectiveOsteoarthritis and Bone DisordersResearch Rheum Tagged with:DisparitiesExercisefootimagingmidfoot oteoarthritisNSAIDsorthoticsPainpodiatryquality of life

A Sound Diagnosis for Glandular Swelling

Hung Vo, MD, Zhichun Lu, MD, & Eugene Kissin, MD  |  August 26, 2025

In this case study, ultrasonography proves useful for excluding a diagnosis of Sjögren’s disease, leading to a correct diagnosis of IgG4-RD.

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:biopsycase reportglandular swellingIgG4-RDimage case reportimagingmimicssalivary glandsSialadenitisSjögren’s Disease supplementUltrasound

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences